GP
GLG Partners’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-47,570
| Closed | -$1.72M | – | 496 |
|
|
2016
Q4 | $1.72M | Sell |
47,570
-3,914
| -8% | -$142K | 0.07% | 220 |
|
|
2016
Q3 | $2.37M | Buy |
51,484
+17,179
| +50% | +$790K | 0.07% | 248 |
|
|
2016
Q2 | $1.72M | Sell |
34,305
-825
| -2% | -$41.4K | 0.05% | 261 |
|
|
2016
Q1 | $1.88M | Sell |
35,130
-305,125
| -90% | -$16.3M | 0.05% | 244 |
|
|
2015
Q4 | $22.3M | Sell |
340,255
-132,716
| -28% | -$8.71M | 0.71% | 30 |
|
|
2015
Q3 | $26.7M | Sell |
472,971
-110,620
| -19% | -$6.25M | 0.71% | 28 |
|
|
2015
Q2 | $34.5M | Buy |
583,591
+463,134
| +384% | +$27.4M | 0.89% | 18 |
|
|
2015
Q1 | $7.51M | Sell |
120,457
-61,672
| -34% | -$3.84M | 0.25% | 111 |
|
|
2014
Q4 | $10.5M | Sell |
182,129
-557,106
| -75% | -$32M | 0.31% | 82 |
|
|
2014
Q3 | $39.7M | Sell |
739,235
-227,713
| -24% | -$12.2M | 0.91% | 17 |
|
|
2014
Q2 | $50.7M | Buy |
966,948
+727,830
| +304% | +$38.2M | 1.21% | 12 |
|
|
2014
Q1 | $12.6M | Buy |
239,118
+164,118
| +219% | +$8.67M | 0.25% | 86 |
|
|
2013
Q4 | $3.01M | Hold |
75,000
| – | – | 0.21% | 97 |
|
|
2013
Q3 | $2.83M | Sell |
75,000
-207,766
| -73% | -$7.85M | 0.26% | 90 |
|
|
2013
Q2 | $11.1M | Buy |
+282,766
| New | +$11.1M | 0.42% | 65 |
|